Boehringer Ingelheim Investigational Site

Prague

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, Myocardial Infarction

Studies at this site

• BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma — Stopped early
• A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) — Stopped early